SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-099508
Filing Date
2020-04-06
Accepted
2020-04-06 16:16:00
Documents
5
Period of Report
2020-05-21
Effectiveness Date
2020-04-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d897717ddef14a.htm DEF 14A 408165
2 GRAPHIC g897717g31s83.jpg GRAPHIC 78215
3 GRAPHIC g897717g34y39.jpg GRAPHIC 28870
4 GRAPHIC g897717g37t55.jpg GRAPHIC 77650
5 GRAPHIC g897717g62r17.jpg GRAPHIC 30086
  Complete submission text file 0001193125-20-099508.txt   705345
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 20777157
SIC: 2834 Pharmaceutical Preparations